Quote:The Right’s Favorite Anti-LGBT Doctor Strikes Again
Dr. Paul McHugh has a long history of anti-science, anti-LGBT stances. That doesn’t stop conservative media from lauding his work.
Samantha Allen
08.23.16 1:45 PM ET
http://www.thedailybeast.com/articles/2016/08...again.html
Former Johns Hopkins psychiatry chair Dr. Paul McHugh has a long history of staking out anti-LGBT positions. But The Washington Examiner and other conservative media outlets would have you believe that McHugh’s statements on LGBT issues are significant because he is a “prominent psychiatrist.”
At least, that’s how the Examiner referred to him after he and Arizona State statistician Dr. Lawrence Mayer published a lengthy paper casting doubt on the scientific consensus around sexual orientation and gender identity.
That paper appears in a recent issue of a journal called The New Atlantis and it has already generated the predictable far-right lovefest.
“Almost Everything the Media Tell You About Sexual Orientation and Gender Identity Is Wrong,” the Daily Signal gleefully declared. The Daily Signal is owned by The Heritage Foundation, a conservative think tank.
The Christian Post weighed in on the paper, too, repeating the researchers’ claim that there is “No Scientific Evidence That People Are Born Gay or Transgender.”
There is plenty of evidence to show that this isn’t McHugh’s first anti-LGBT rodeo.
In 2006, he was quoted as saying that sexual abuse in the Catholic Church was the result of “homosexual predation on American Catholic youth,” as GLAAD noted. Four years later, he filed an amicus brief supporting California’s same-sex marriage ban, arguing that “sexual orientation is, in part, a choice.”
In 2014, McHugh wrote a widely-cited anti-transgender op-ed for the Wall Street Journal that contradicts position statements from several major medical organizations including the American Medical Association and the American Psychiatric Association
Most recently, in the spring of 2016, he helped write a position paper for the American College of Pediatricians (ACPeds), a small Gainesville, Florida-based organization that the Southern Poverty Law Center has called “an anti-LGBT hate group.” That position paper called health care for trans youth a form of “child abuse.”
“It may be an intrinsic problem of American psychiatry to fall into a craze or cult-like misdirection once a decade,” McHugh previously told The Daily Beast about his involvement with that ACPeds paper. “Transgenderism seems to be this decade’s version.”
So it’s no surprise to see McHugh’s name crop up yet again in connection with another round of headlines questioning LGBT identities.
In their new paper, McHugh and Mayer express skepticism over the concept of “sexual orientation,” writing that “we may have some reasons to doubt the common assumption that in order to live happy and flourishing lives, we must somehow discover this innate fact about ourselves that we call sexuality or sexual orientation, and invariably express it through particular patterns of sexual behavior or a particular life trajectory.”
With regards to transgender people, they advocate taking “a skeptical view toward the claim that sex-reassignment procedures provide the hoped-for benefits.” They especially question the provision of health care for transgender children, writing that they are “disturbed and alarmed by the severity and irreversibility of some interventions being publicly discussed and employed for children.”
On all of these counts, McHugh and Mayer are at odds with the positions of major physicians’ associations.
The 117,575-member American Psychological Association (APA), for instance, has long acknowledged sexual orientation, defining it as “an enduring pattern of emotional, romantic and/or sexual attractions to men, women or both sexes.”
If sexual orientation is a choice, shouldn't everyone
Top 10 Most Recent News Articles
Lundbeck's Board Leadership Transitions into New Era
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Faith and Resilience in China: The Legacy of the Long March
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
UEG's New Advisory Board: Elevating Patient Voices
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue ReadingTop 5 Most Recently Viewed Articles
Westgate Energy's Drilling Accomplishments and Financial Update
Overview of Recent Developments Westgate Energy Inc. (TSXV: WGT) has released its latest financial results along with updates on its three well drilling program. The Company is thrilled to share positive advancements since it has successfully filed its unaudited financial and operational outcomes covering a significant quarter in its operations. Financial Highlights The...
Continue Reading
Warren Buffett's Investment Strategy: A Guide for Investors
Insights into Buffett's Investment Philosophy Warren Buffett is a name that resonates with wise investing. Over the years, he’s built his reputation on a foundation of simplicity and strategic insight. While many contemporary investors chase after fleeting trends, Buffett sticks to the fundamentals, offering a timeless roadmap for achieving long-term success in the...
Continue Reading
TeleRare Health Introduces Virtual Genetic Consults for Patients
TeleRare Health Launches Virtual Genomic Consultation Service TeleRare Health has proudly announced the commencement of its Virtual Genomic Consults, providing immediate support for patients facing challenges with rare diseases and genetic conditions. This innovative initiative is particularly beneficial for those navigating the complex world of rare and genetic disorders...
Continue Reading
BrowserStack Unveils Major Employee Stock Ownership Program
BrowserStack Launches $125 Million ESOP and Share Buyback BrowserStack, a leader in software testing solutions, has made waves with their announcement of a substantial $125 million Employee Stock Ownership Plan (ESOP) and share buyback program. Benefiting over 500 current and former employees along with early investors, this initiative marks the company's third buyback,...
Continue Reading
Insight into Banijay Group's Weekly Share Activities
Banijay Group Share Transactions Overview Banijay Group N.V. is a name that resonates within the global entertainment industry, orchestrating an array of transactions that reveal its market dynamics. Recently, the company reported various share transactions conducted between June 23 and June 30. This disclosure aligns with the authorization granted during the recent...
Continue Reading